Q: CLPT Hello, what is your opinion of this small business in the medical space ? Do you believe their technologies are unique ? Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Where do you see Stryker and Becton Dickinson going forward with the Delta and now Omnicon which is way more transmissible?
If hospitalisation increases with Omnicon and surgeries are held back again, will this affect both companies and will this cause these 2 stocks to plunge?
thank you
If hospitalisation increases with Omnicon and surgeries are held back again, will this affect both companies and will this cause these 2 stocks to plunge?
thank you
Q: Can you comment on the recent quarter / earnings release? Based on a previous question and response the company seems to be accelerating revenue with over 190% growth quarter over quarter and have provided guidance of over $40m in revenue for calendar 2022. Is this a good entry point as the company seems to be at an inflection point?
-
iShares S&P/TSX Capped Consumer Staples Index ETF (XST $62.92)
-
State Street Consumer Staples Select Sector SPDR ETF (XLP $77.04)
-
iShares Biotechnology ETF (IBB $175.21)
Q: can you recommend a US and Canadian defensive ETF and a US healthcare ETF?
thanks
thanks
-
WELL Health Technologies Corp. (WELL $4.13)
-
WELL Health Technologies Corp. 5.50% Convertible Senior Unsecured Debentures (WELL.DB $99.90)
Q: Good afternoon,
I was up 30% on WELL but I am now down 20%. I know you are positive on the stock over the next few years. I do not need to sell it but I'm thinking of (1) selling it for tax loss purposes and buying it back after 30 days, or (2) buying more now to average down, Alternatively, (3) I could sell the shares for tax loss purposes and buy the new convertible debentures which pay 5.5% and are convertible at a share price of $9.23. Al things being equal which looks like the best approach over the next 3 years? if it is to buy the debentures what is the ticker symbol for them? Thanks.
I was up 30% on WELL but I am now down 20%. I know you are positive on the stock over the next few years. I do not need to sell it but I'm thinking of (1) selling it for tax loss purposes and buying it back after 30 days, or (2) buying more now to average down, Alternatively, (3) I could sell the shares for tax loss purposes and buy the new convertible debentures which pay 5.5% and are convertible at a share price of $9.23. Al things being equal which looks like the best approach over the next 3 years? if it is to buy the debentures what is the ticker symbol for them? Thanks.
Q: I've been considering adding MRK to my portfolio - Would you be comfortable with this company? Why the recent plunge? I already own ABBV and MED.
Q: Just joined 5i Would like to know where you stand with Well Health. Bought it about 18-20 months ago on Peter’s research.
Thx
Phil G
Thx
Phil G
Q: hello 5i Research team,
I understand that the entire sector has been weak for some time. WELL is currently at its 52 week low. Based on technical analysis, what is the next support level? Could you compare WELL stock performance with a basket of North American competitors (name the list of the companies in your basket) since March 1st 2021 when WELL was at 9$ and comment. What could be catalysts for the sector? Have you seen some signs of consolidation in the sector?
Thank you for your collaboration, Eric
I understand that the entire sector has been weak for some time. WELL is currently at its 52 week low. Based on technical analysis, what is the next support level? Could you compare WELL stock performance with a basket of North American competitors (name the list of the companies in your basket) since March 1st 2021 when WELL was at 9$ and comment. What could be catalysts for the sector? Have you seen some signs of consolidation in the sector?
Thank you for your collaboration, Eric
Q: Peter; With Omicron and possibly more variants in our future would PFE be a good hedge ? Thanks. Rod
Q: Your thought please about guardian health.
What is the consensus on the street?
It appears your associates do not have it in their portfolio anymore.
Any reason why and would you prefer VEEV in the sector?
If so ,why would you prefer VEEV?
What is the consensus on the street?
It appears your associates do not have it in their portfolio anymore.
Any reason why and would you prefer VEEV in the sector?
If so ,why would you prefer VEEV?
Q: Takeda is near its 52 week lows, with most of the drop in the past few months. Is this a potential buy opportunity (I don't currently hold this stock) or are there some major issues or concerns to be aware of?
Q: This company has been posting some good growth. Do you think it would be a good growth investment? Also, it has been in business for 30-years. Do you know when they went public?
Q: Between SYK & WBA which would you prefer for a 5 year total return investment and why.
Q: Good evening,
I looked everywhere for news that can justify the over 15% move in the stock today. No press release on their website?
Do you see any news or have you any idea what's behind the move?
Thanks, grateful as always!
I looked everywhere for news that can justify the over 15% move in the stock today. No press release on their website?
Do you see any news or have you any idea what's behind the move?
Thanks, grateful as always!
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $72.71)
-
Harvest Healthcare Leaders Income ETF (HHL $7.96)
Q: Hi Peter, Ryan, and Team,
If one doesn't need the income that HHL provides, and can buy and sell XHC commission-free, but not HHL, how would you rank these two ETFs? XHC appears to have a better long-term chart.
Thanks as always for your valued advice.
If one doesn't need the income that HHL provides, and can buy and sell XHC commission-free, but not HHL, how would you rank these two ETFs? XHC appears to have a better long-term chart.
Thanks as always for your valued advice.
Q: Any comments on DR as it has been going down steadily over the last couple of weeks. I've been trying to sell into the previous strength. My intent is to exit this position and I am prepared to just proceed but if this current weakness is tax loss selling or a fund exiting their position I would be prepared to wait for the new year. I've got about a 25% loss on my position.
Q: Peter please give me your opinion on HHL. My wife and I are seniors and depend on our investments for income. Looking for as safe as possible div. with a high yield. We already own Canadian banks, pipelines, power generators. and some reits. Will this give us some diversification in the medical field Any other suggestions? Thanks Ken
-
Illumina Inc. (ILMN $149.29)
-
Intuitive Surgical Inc. (ISRG $597.50)
-
Veeva Systems Inc. Class A (VEEV $237.22)
-
Teladoc Health Inc. (TDOC $7.80)
-
Guardant Health Inc. (GH $111.93)
Q: GH, TDOC, VEEV: Which stock is your favorite and would you buy all 3. If there are other you prefer over these, please list them? Risk is not an issue so no dividends. Would you purchase now or wait until things settle down?
Thanks for your service!
Thanks for your service!
-
Regeneron Pharmaceuticals Inc. (REGN $799.14)
-
AbbVie Inc. (ABBV $227.65)
-
Abbott Laboratories (ABT $127.73)
-
Pfizer Inc. (PFE $25.67)
-
Stryker Corporation (SYK $366.18)
Q: Looking to invest in the health care sector. Please rank these companies using the criteria of possibility of capital gains, relative security if inflation becomes a problem and fundamental strength. If you have other choices I would welcome the ideas.
Q: Looking for strong growth going forward. Which of these health care companies shows the most promise?